APPEAL-1: A multiple-country European survey assessing the psychosocial impact of peanut allergy.
bullying
coping
daily life
peanut allergy
psychosocial impacts
Journal
Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
20
01
2020
revised:
23
03
2020
accepted:
16
04
2020
pubmed:
14
5
2020
medline:
15
5
2021
entrez:
14
5
2020
Statut:
ppublish
Résumé
Peanut allergy (PA) is a common, potentially life-threatening and typically lifelong condition with a significant burden of illness. However, information is lacking on how persons with PA (PwPA) and their caregivers perceive the psychosocial impact of living with PA. The Allergy to Peanuts imPacting Emotions And Life 1 (APPEAL-1) survey, conducted across Europe, investigated the experience and impact of living with PA. Here, we report data evaluating the psychosocial impact of PA on PwPA and their caregivers. Allergy to Peanuts imPacting Emotions And Life study 1 was an online survey conducted in eight European countries. Representatives of eight patient advocacy groups and five healthcare-research specialists developed the survey. Eligible respondent groups included the following: adults diagnosed with PA (self-report); parent/nonparent caregivers (proxy-report for a child with PA); and parent/nonparent caregivers (self-report of PA impact on themselves). Of 1846 total study respondents, 419 were adults with PA (self-report); 546 were parents/caregivers (proxy-report); and 881 were parents/caregivers (self-report). Most respondents reported lifestyle restrictions regarding food (84%-93%) and additional domains including parties and socializing, holiday activities and destinations, and taking public transport (53%-89%). Approximately 40% rated themselves as "very" frustrated and "very" stressed. Two-thirds (65%) felt socially isolated; 43% were bullied. Less than half felt confident in knowing when to use an adrenaline autoinjector. Several intercountry differences were observed such as high levels of uncertainty and stress in respondents from Ireland, highest rates of anxiety in respondents from Germany, and social exclusion and isolation most common in respondents from France. Peanut allergy imposes an adverse psychosocial impact on patients and caregivers, leading to frustration, stress and isolation. Attention to the impact of PA is needed in research and clinical practice to improve PA healthcare and public education programmes.
Sections du résumé
BACKGROUND
Peanut allergy (PA) is a common, potentially life-threatening and typically lifelong condition with a significant burden of illness. However, information is lacking on how persons with PA (PwPA) and their caregivers perceive the psychosocial impact of living with PA. The Allergy to Peanuts imPacting Emotions And Life 1 (APPEAL-1) survey, conducted across Europe, investigated the experience and impact of living with PA. Here, we report data evaluating the psychosocial impact of PA on PwPA and their caregivers.
METHODS
Allergy to Peanuts imPacting Emotions And Life study 1 was an online survey conducted in eight European countries. Representatives of eight patient advocacy groups and five healthcare-research specialists developed the survey. Eligible respondent groups included the following: adults diagnosed with PA (self-report); parent/nonparent caregivers (proxy-report for a child with PA); and parent/nonparent caregivers (self-report of PA impact on themselves).
RESULTS
Of 1846 total study respondents, 419 were adults with PA (self-report); 546 were parents/caregivers (proxy-report); and 881 were parents/caregivers (self-report). Most respondents reported lifestyle restrictions regarding food (84%-93%) and additional domains including parties and socializing, holiday activities and destinations, and taking public transport (53%-89%). Approximately 40% rated themselves as "very" frustrated and "very" stressed. Two-thirds (65%) felt socially isolated; 43% were bullied. Less than half felt confident in knowing when to use an adrenaline autoinjector. Several intercountry differences were observed such as high levels of uncertainty and stress in respondents from Ireland, highest rates of anxiety in respondents from Germany, and social exclusion and isolation most common in respondents from France.
CONCLUSIONS
Peanut allergy imposes an adverse psychosocial impact on patients and caregivers, leading to frustration, stress and isolation. Attention to the impact of PA is needed in research and clinical practice to improve PA healthcare and public education programmes.
Identifiants
pubmed: 32400915
doi: 10.1111/all.14363
pmc: PMC7689848
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2899-2908Informations de copyright
© 2020 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Références
Clin Exp Allergy. 2016 Apr;46(4):610-20
pubmed: 26588036
J Allergy Clin Immunol. 2015 May;135(5):1257-66.e1-2
pubmed: 25725989
J Allergy Clin Immunol. 2018 Jan;141(1):41-58
pubmed: 29157945
Allergy Asthma Proc. 2019 Sep 1;40(5):290-294
pubmed: 31514787
Clin Pediatr (Phila). 2011 Nov;50(11):1045-51
pubmed: 21685213
Allergy. 2015 Jun;70(6):616-24
pubmed: 25627424
J Allergy Clin Immunol. 2001 Feb;107(2):367-74
pubmed: 11174206
Ann Allergy Asthma Immunol. 2014 Jul;113(1):63-68.e1
pubmed: 24795291
Hosp Pediatr. 2016 May;6(5):269-74
pubmed: 27102912
J Investig Allergol Clin Immunol. 2019;29(5):357-364
pubmed: 30411700
Allergy. 2015 Jul;70(7):855-63
pubmed: 25850463
J Allergy Clin Immunol. 2018 Mar;141(3):982-990
pubmed: 29174346
Ann Allergy Asthma Immunol. 2006 Mar;96(3):415-21
pubmed: 16597075
Ann Allergy Asthma Immunol. 2010 Oct;105(4):282-6
pubmed: 20934627
J Allergy Clin Immunol. 2008 Mar;121(3):731-6
pubmed: 18234313
J Allergy Clin Immunol Pract. 2016 Nov - Dec;4(6):1143-1146
pubmed: 27283056
J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1169-1178
pubmed: 28888247
J Allergy Clin Immunol. 2011 Mar;127(3):623-30.e1
pubmed: 21236479
Immunol Allergy Clin North Am. 2015 Feb;35(1):45-59
pubmed: 25459576
J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1180-1191
pubmed: 28888248
Allergy. 2020 Nov;75(11):2899-2908
pubmed: 32400915
Pediatr Allergy Immunol. 2018 Nov;29(7):740-746
pubmed: 29974514
J Allergy Clin Immunol. 2016 Apr;137(4):1128-1137.e1
pubmed: 26806049
Pediatrics. 2017 Aug;140(2):
pubmed: 28739655
Disabil Rehabil. 2018 Jan;40(1):116-120
pubmed: 27830936
Health Soc Work. 2005 Nov;30(4):325-35
pubmed: 16323724
Health Psychol Res. 2013 Sep 23;1(3):e27
pubmed: 26973912
Pediatrics. 1993 Feb;91(2):430-5
pubmed: 8424023
Pediatrics. 2013 Jan;131(1):e10-7
pubmed: 23266926
Allergy. 2014 Aug;69(8):992-1007
pubmed: 24816523
PLoS One. 2019 Apr 24;14(4):e0214625
pubmed: 31017913
Ann Allergy Asthma Immunol. 2017 Aug;119(2):164-169
pubmed: 28711194
Clin Exp Allergy. 2000 Aug;30(8):1135-43
pubmed: 10931121
J Allergy Clin Immunol. 2014 Nov;134(5):1016-25.e43
pubmed: 25174862
Pediatrics. 2018 Dec;142(6):
pubmed: 30455345
Clin Exp Allergy. 2012 Feb;42(2):284-92
pubmed: 22181034
Pediatr Allergy Immunol. 2003 Oct;14(5):378-82
pubmed: 14641608
Curr Opin Pediatr. 2017 Aug;29(4):497-502
pubmed: 28509782
J Asthma Allergy. 2018 Jun 20;11:143-151
pubmed: 29950873
Allergy. 2009 Mar;64(3):461-8
pubmed: 19076542
Allergy. 2020 Nov;75(11):2920-2935
pubmed: 32438514
Allergy Asthma Proc. 2015 Jan-Feb;36(1):58-64
pubmed: 25562557
J Pediatr. 2018 Jan;192:223-228.e1
pubmed: 29246346
Clin Transl Allergy. 2015 Apr 02;5:16
pubmed: 25861446
J Allergy Clin Immunol. 2014 Dec;134(6):1462-1463.e6
pubmed: 25441300
Allergy. 2018 Apr;73(4):799-815
pubmed: 29205393
Med Humanit. 2005 Jun;31(1):12-6
pubmed: 16167409